Q2 2025 Kaldvik AS Earnings Call Transcript
Good morning, everyone. I'm Vidar Aspehaug, new Interim CEO of Kaldvik, and I'm pleased to welcome you to the presentation of our second quarter results for 2025. Joining me today is our CFO, Robert Robertsson, and together, we'll walk you through the key highlights and developments for the past quarter. After the presentation, we'll open the floor for questions. And as before, you're welcome to submit them by e-mail to [email protected].
But first, a short introduction of myself. I'm, as I say, Vidar Aspehaug, and I've been working with Kaldvik since November '21 and been in the Executive Management since August '22. I'm a fish health biologist with a PhD in Virology, specialized in handling the ISA virus. I cofounded PatoGen, the major diagnostic laboratory for the aquaculture industry in 2005 and was the CEO there for eight years until I moved into a position as Business Development Officer, focusing then on fish health challenges in Norway, Chile and Scotland. And I worked with PatoGen until we sold the company in 2021.
In
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
